Literature DB >> 10560120

ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.

G W Hunninghake1, U Costabel, M Ando, R Baughman, J F Cordier, R du Bois, A Eklund, M Kitaichi, J Lynch, G Rizzato, C Rose, O Selroos, G Semenzato, O P Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10560120

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN： 1124-0490            Impact factor:   0.670


× No keyword cloud information.
  266 in total

1.  [Pulmonary fibrosis. Classification, diagnosis, therapy].

Authors:  U Costabel; J Guzman
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

Review 2.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

3.  Unilateral pulmonary hilar tumor mass: is it always lung cancer?

Authors:  Claudia Lucia Toma; Stefan Dumitrache-Rujinski; Ionela Nicoleta Belaconi; Bianca Paraschiv; Mihai Alexe; Aneta Serbescu; Diana Leonte; Miron Alexandru Bogdan
Journal:  Maedica (Bucur)       Date:  2013-03

Review 4.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

5.  Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.

Authors:  W P Drake; B W Richmond; K Oswald-Richter; C Yu; J M Isom; J A Worrell; G R Shipley
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2013-11-25       Impact factor: 0.670

6.  Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis.

Authors:  Seref Kul; Hatice Kutbay Ozcelik; Huseyin Uyarel; Gultekin Karakus; Tolga Sinan Guvenc; Murat Yalcınsoy; Emin Asoglu; Ahu Sarbay Kemik; Abdurrahman Tasal; Sinem Gungor; Ercan Karaarslan; Levent Kart; Omer Goktekin
Journal:  Lung       Date:  2014-04-29       Impact factor: 2.584

7.  Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis.

Authors:  David E Victorson; Seung Choi; Marc A Judson; David Cella
Journal:  Qual Life Res       Date:  2013-11-09       Impact factor: 4.147

8.  Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.

Authors:  Valentine Heidelberger; Saskia Ingen-Housz-Oro; Alicia Marquet; Matthieu Mahevas; Didier Bessis; Laurence Bouillet; Frédéric Caux; Catherine Chapelon-Abric; Sébastien Debarbieux; Emmanuel Delaporte; Anne-Bénédicte Duval-Modeste; Olivier Fain; Pascal Joly; Sylvain Marchand-Adam; Jean-Benoît Monfort; Nicolas Noël; Thierry Passeron; Marc Ruivard; Françoise Sarrot-Reynauld; Denis Verrot; Diane Bouvry; Laurence Fardet; Olivier Chosidow; Pascal Sève; Dominique Valeyre
Journal:  JAMA Dermatol       Date:  2017-07-01       Impact factor: 10.282

9.  Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors.

Authors:  Aggeliki Rapti; Vasileios Kouranos; Elias Gialafos; Konstantina Aggeli; John Moyssakis; Anastasios Kallianos; Charalampos Kostopoulos; Ourania Anagnostopoulou; Petros P Sfikakis; Athol U Wells; George E Tzelepis
Journal:  Lung       Date:  2012-12-11       Impact factor: 2.584

Review 10.  Rare localizations of bone sarcoidosis: two case reports and review of the literature.

Authors:  Elena Bargagli; C Olivieri; F Penza; P Bertelli; S Gonnelli; L Volterrani; P Rottoli
Journal:  Rheumatol Int       Date:  2009-12-15       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.